Company / Working Capital
FILANA THERAPEUTICS, INC. Working Capital History
FY2011-FY2015 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$29.1M
FY2015
5-year range
$29.1M / $85.2M
FY2011-FY2015
Trend
-27.1%
vs FY2014
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $48M to $29M over the past 2 years.
Based on SEC 10-K filings.
$29M in FY2015 with a 3-year CAGR of -14.4%.
Declined from $48M to $29M over the past 2 years.
Working Capital over time
Growth rates
- 3-Year CAGR
- -14.4%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of -14.4%, indicating a declining trend.
- In FY2015, working capital decreased 27.1% year-over-year.
- Peak working capital was recorded in FY2011.
Company context
Key Data Points
- Altman Z-Score 3.76 (safe zone, above 2.9 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2015 | $29.1M | -27.1% |
| FY2014 | $40.0M | -17.2% |
| FY2013 | $48.3M | +3.9% |
| FY2012 | $46.5M | -45.4% |
| FY2011 | $85.2M | - |
As of FY2015 · SEC 10-K · Updated Jun 24, 2026